BGI Launches George Church Institute of RegenesisGenomeWebNEW YORK (GenomeWeb) – BGI said today that is has launched the George Church Institute of Regenesis, which plans to focus on synthetic biology technologies and applications, and will collaborate… Continue reading
BGI Launches George Church Institute of RegenesisGenomeWebNEW YORK (GenomeWeb) – BGI said today that is has launched the George Church Institute of Regenesis, which plans to focus on synthetic biology technologies and applications, and will collaborate… Continue reading
|
Long-lasting blood vessel repair in animals via stem cells
Science Daily Stem cell researchers at Emory University School of Medicine have made an advance toward having a long-lasting “repair caulk” for blood vessels. The research could form the basis of a treatment for peripheral artery disease, derived from a patient’s … |
|
Cutting-edge immunotherapy treatment approved for another deadly cancer
Kankakee Daily Journal The one-time infusion, known as CAR T-cell therapy, is made by Kite Pharma, which is based in Santa Monica, Calif., and recently was bought by Gilead Sciences for $11.9 billion. Kite announced Wednesday the treatment’s brand name will be Yescarta and … |
Newshawk Time |
Global Cancer Immunotherapy Market Report 2017-2022
PR Newswire (press release) reveals that the cancer immunotherapy space will be a significant revenue generator (excess of $80 billion) for the biopharmaceutical industry by 2020. The market has been supported by the approval of Bristol-Myers’ Yervoy drug for melanoma, BMS’s … Global Cancer Immunotherapy Market Analysis & Forecast to 2022 – Research and MarketsBusiness Wire (press release) Cancer Immunotherapy Market Analysis, Industry Chain Related Technical Experts Analysis and Forecasts Till 2021Digital Journal Immunotherapy Drugs Market : Size, Share, Analysis and Forecast 2025Medgadget (blog) |
|
Duration of Immunotherapy for NSCLC
OncLive So, it seems to me that probably the most important study to be done is not this type of study, but it’s a study that is looking about the opportunity to continue immunotherapy for those patients who are in CR or PR. And probably we need to do a … |
Parkinson’s News Today |
Voyager’s AADC Gene Therapy Shows Promise as Maintenance Therapy for Parkinson’s
Parkinson’s News Today The company presented ongoing Phase 1b trial (NCT01973543) results at the Oct. 17-20 Congress of the European Society of Gene and Cell Therapy (ESGCT) in Berlin, in a talk titled “Intraputaminal AADC gene therapy for advanced Parkinson’s disease: … |
Genetic Engineering & Biotechnology News |
New Version of CRISPR, Developed by Feng Zhang–Led Team, Can Target and Edit RNA
Genetic Engineering & Biotechnology News A research team led by Feng Zhang, Ph.D., has developed a new version of the gene-editing tool CRISPR (clustered regularly interspaced short palindromic repeats) that offers several advantages over its familiar DNA-editing counterpart through its … Gene-editing tool CRISPR can now manipulate more types of genetic materialThe Verge CRISPR 2.0 Is Here, and It’s Way More PreciseMIT Technology Review New CRISPR tool alters RNA for wider gene editing applicationsEngadget Science Magazine –WIRED –STAT –Science all 69 news articles » |